Polarean Imaging Company Description

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States.

It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform.

The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags.

Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.

Polarean Imaging plc

Country	United Kingdom
Founded	2016
Industry	Medical Devices
Sector	Healthcare
Employees	29
CEO	Christopher Von Jako

Contact Details

Address: 27-28 Eastcastle Street London, W1W 8DH United Kingdom
Website	polarean.com

Stock Details

Ticker Symbol	PLLWF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	GB00BF3DT583
SIC Code	3821

Key Executives

Name	Position
Dr. Christopher Richard Von Jako Ph.D.	Chief Executive Officer and Director
Dr. Kenneth Paul West Ph.D.	Chairman of the Board
Dr. Bastiaan Driehuys Ph.D.	Founder, Chief Scientific Officer and Director
Charles Fremont Osborne Jr.	Chief Financial Officer and Director
Neil Wadehra	Vice President of Operations
Alex Dusek	Chief Commercial Officer
Dr. Chase Hall M.D.	Chief Medical Advisor
Stephen Austin	Company Secretary